During months of dedicated work with 1-to-1 workshops with Amgen, Bayer, Beiersdorf, and Boehringer Ingelheim Cardiolyse amongst other 16 startups met the representatives from the pharma companies. All of the startups were given the opportunity to pitch our solutions to the pharma companies, who helped us validate the business concepts and provide us with critical feedback on our development plans.
The Amgen Challenge is dedicated to encouraging continuity in treatment strategy and treatment optimization for post-myocardial infarction patients
Cardiolyse presented to AMGEN our Post Myocardium Infarction Rehabilitation Remote monitoring Platform that delivers a predictive analytic tool to identify high-risk patients and holistic support to post-MI patients after hospital discharge.
These tools provide essential information for patients' treatment strategies and lifestyle changes, optimizing nursing time in the follow-up of patients.
We are thrilled to announce that Cardiolyse won the AMGEN Challenge of 2020 EIT Health Startups Meet Pharma at the final Module 3.